Cancer diagnostics News and Research

RSS

Black Americans' beliefs may hamper lung cancer prevention and care

Blacks in the United States are less certain than whites about recommendations to prevent lung cancer and are more fearful of having symptoms evaluated, beliefs that may keep them from seeking timely treatment for the disease, researchers from Dana-Farber Cancer Institute reported at the American Society of Clinical Oncology's annual meeting in Chicago.

5 Jun 2007

Biomoda files additional patent protection for lung cancer detection technology

Biomoda, Inc. has confirmed that it is continuing to expand its patent portfolio with a unique patent pending for the use of its patented porphyrin molecule to detect different cell variations of lung cancer.

1 Jun 2007

Study identifies patients' reasons for quitting jobs after treatment for head and neck cancer

After treatment, 38.1 percent of patients with head and neck cancer who were employed at the time of cancer diagnosis reported discontinuing work because of their cancer and treatment, according to a report in the May issue of Archives of Otolaryngology-Head & Neck Surgery.

22 May 2007

University of Leicester launches one-year Masters degree in Cancer Chemistry

The degree is the first of its kind in the country, fulfilling a need to provide graduates with skills in the chemistry and biology of cancer, and direct experience of some of the very latest research in the field.

22 May 2007

Link between periodontitis and tongue cancer

Researchers at the University at Buffalo and Roswell Park Cancer Institute have shown for the first time that an association exists between long-standing periodontitis, or gum disease, and risk of tongue cancer.

22 May 2007

Biomarker discovery bodes well for better cancer diagnostics

While new findings from Ohio State University scientists suggest a genetic marker that could help distinguish between chronic pancreatitis and pancreatic cancer and gauge who will do well with cancer treatment, a pharmacologist at the Kimmel Cancer Center at Jefferson in Philadelphia sees the discovery as much more.

2 May 2007

Two-photon absorption imaging of hemoglobin

In an advance that can potentially assist cancer diagnosis, a new optical technique provides high-resolution, three-dimensional images of blood vessels by taking advantage of the natural multiple-photon-absorbing properties of hemoglobin, the red-blood-cell molecule that carries oxygen throughout the bloodstream.

1 May 2007

Childhood sarcoma increases risk of blood clots

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event (TE) in their veins.

20 Apr 2007

Factors that influence late stage cancer diagnosis

Researchers from the Keck School of Medicine of the University of Southern California (USC) found that patients who received a later stage cancer diagnosis were likely to be living in an unsafe neighborhood, using public transportation and traveling at least 45 minutes to get to a doctor's office.

16 Apr 2007

Socio-ecological and cultural factors attributed to later stage cancer diagnosis

16 Apr 2007

Health disparities in access to healthcare

Minority individuals are much more likely to develop and die from cancer than the general U.S. population.

16 Apr 2007

New, potentially more accurate method for diagnosing breast cancer

By combining two techniques, magnetic resonance imaging (MRI) and near-infrared optics, researchers at Dartmouth College and Dartmouth Medical School may have devised a new, potentially more accurate method for diagnosing breast cancer.

14 Apr 2007

FASgen awarded grant for refinement of its serum fatty acid synthase

FASgen has announced that it has been awarded an SBIR grant from National Cancer Institute for refinement of its serum FAS (fatty acid synthase) ELISA cancer diagnostic test, FAS- Detect ELISA.

10 Apr 2007

Newmarket, Ontario to establish world-class cancer centre

Princess Margaret Hospital (PMH) will share its latest knowledge, research in cancer care, and expertise to assist Southlake Regional Health Centre (Southlake) in establishing a world-class cancer centre through a formal affiliation between a world leader in cancer care and the newly established cancer program in the Newmarket-based hospital.

5 Apr 2007

Reauthorization of the National Breast and Cervical Cancer Early Detection Program gives women access to life-saving early detection

For the past four years, Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists have tirelessly advocated for reauthorization of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).

4 Apr 2007

Although breast cancer mortality has declined as a whole, declines are greatest for women under 70

A new study shows that recent declines in breast cancer mortality rates have been most significant among women with estrogen receptor (ER)-positive tumors and women younger than 70.

4 Apr 2007

Potential new cancer diagnosis and treatment options

By recognizing sugars, a technique developed by University of Michigan analytical chemist Kristina Hakansson sets the stage for new cancer diagnosis and treatment options.

2 Apr 2007

Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast

The international research team found that MRI, or magnetic resonance imaging, detected cancer in the opposite breast in 30 of 969 women (3.1 percent) who had recently been diagnosed with cancer in one breast only. The cancers in the opposite breast were missed by previous mammography and clinical exam.

31 Mar 2007

American Cancer Society issues recommendation on MRI for breast cancer screening

An expert panel convened by the American Cancer Society has developed new recommendations for the use of magnetic resonance imaging (MRI) for women at increased risk for breast cancer, and recommends annual screening using MRI in addition to mammography for women with a 20-25 percent or greater lifetime risk of the disease.

29 Mar 2007

MRI evaluation of the contralateral breast in women recently diagnosed with breast cancer

Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one breast detected over 90 percent of cancers in the other breast that were missed by mammography and clinical breast exam at initial diagnosis, according to a new study.

28 Mar 2007

Cancer diagnostics News and Research

Black Americans' beliefs may hamper lung cancer prevention and care

Biomoda files additional patent protection for lung cancer detection technology

Study identifies patients' reasons for quitting jobs after treatment for head and neck cancer

University of Leicester launches one-year Masters degree in Cancer Chemistry

Link between periodontitis and tongue cancer

Biomarker discovery bodes well for better cancer diagnostics

Two-photon absorption imaging of hemoglobin

Childhood sarcoma increases risk of blood clots

Factors that influence late stage cancer diagnosis

Socio-ecological and cultural factors attributed to later stage cancer diagnosis

Health disparities in access to healthcare

New, potentially more accurate method for diagnosing breast cancer

FASgen awarded grant for refinement of its serum fatty acid synthase

Newmarket, Ontario to establish world-class cancer centre

Reauthorization of the National Breast and Cervical Cancer Early Detection Program gives women access to life-saving early detection

Although breast cancer mortality has declined as a whole, declines are greatest for women under 70

Potential new cancer diagnosis and treatment options

Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast

American Cancer Society issues recommendation on MRI for breast cancer screening

MRI evaluation of the contralateral breast in women recently diagnosed with breast cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News